Status:
COMPLETED
An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Coronary Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate additional cholesterol lowering effects in patients with coronary heart disease by giving an investigational drug with a patient's current approved choleste...
Detailed Description
The duration of treatment is 10 weeks.
Eligibility Criteria
Inclusion
- Patients with elevated cholesterol and coronary heart disease
Exclusion
- Patients whose cholesterol levels measure within acceptable ranges as specified by the study requirements
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2004
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT00092638
Start Date
May 1 2003
End Date
August 1 2004
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.